白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2010年
11期
663-665
,共3页
张秀莲%张伟华%侯素敏%陈玮%陶洁
張秀蓮%張偉華%侯素敏%陳瑋%陶潔
장수련%장위화%후소민%진위%도길
白血病,髓样,急性%高白细胞%白细胞介素-1β%白血病浸润
白血病,髓樣,急性%高白細胞%白細胞介素-1β%白血病浸潤
백혈병,수양,급성%고백세포%백세포개소-1β%백혈병침윤
Leukemia,myeloid,acute%Hyperleukocytic%Interleukin-1beta%Leukemia infiltration
目的 检测白细胞介素-1β(IL-1β)在急性髓系白血病(AML)高白细胞患者外周血中的表达,探讨其在细胞淤滞及向组织浸润中的作用.方法 用酶联免疫吸附法(ELISA)测定83例初治AML患者(其中16例为高白细胞白血病患者)血清中IL-1β的含量,比较高白细胞组与非高白细胞组以及浸润组与非浸润组的差别.以40名健康献血员为对照.结果 AML组血清中IL-1β的含量[(88.23±36.30)pg/ml]高于健康对照组[(29.56±15.53)pg/ml],差异有统计学意义(P<0.01);AML高白细胞组血清中IL-1β含量显著高于非高白细胞组[(136.67±65.68)pg/ml比(69.85±48.35)pg/ml].IL-1β与外周血白细胞呈直线相关关系(r=0.74,P<0.01).浸润组与非浸润组血清中IL-1β水平为:(111.31±57.35)pg/ml比(79.68±43.42)pg/ml,差异有统计学意义.结论 AML患者血清IL-1 β水平与其外周血白细胞数量有关,在一定程度上可反映疾病的病情,可能参与了白血病细胞组织浸润的机制.
目的 檢測白細胞介素-1β(IL-1β)在急性髓繫白血病(AML)高白細胞患者外週血中的錶達,探討其在細胞淤滯及嚮組織浸潤中的作用.方法 用酶聯免疫吸附法(ELISA)測定83例初治AML患者(其中16例為高白細胞白血病患者)血清中IL-1β的含量,比較高白細胞組與非高白細胞組以及浸潤組與非浸潤組的差彆.以40名健康獻血員為對照.結果 AML組血清中IL-1β的含量[(88.23±36.30)pg/ml]高于健康對照組[(29.56±15.53)pg/ml],差異有統計學意義(P<0.01);AML高白細胞組血清中IL-1β含量顯著高于非高白細胞組[(136.67±65.68)pg/ml比(69.85±48.35)pg/ml].IL-1β與外週血白細胞呈直線相關關繫(r=0.74,P<0.01).浸潤組與非浸潤組血清中IL-1β水平為:(111.31±57.35)pg/ml比(79.68±43.42)pg/ml,差異有統計學意義.結論 AML患者血清IL-1 β水平與其外週血白細胞數量有關,在一定程度上可反映疾病的病情,可能參與瞭白血病細胞組織浸潤的機製.
목적 검측백세포개소-1β(IL-1β)재급성수계백혈병(AML)고백세포환자외주혈중적표체,탐토기재세포어체급향조직침윤중적작용.방법 용매련면역흡부법(ELISA)측정83례초치AML환자(기중16례위고백세포백혈병환자)혈청중IL-1β적함량,비교고백세포조여비고백세포조이급침윤조여비침윤조적차별.이40명건강헌혈원위대조.결과 AML조혈청중IL-1β적함량[(88.23±36.30)pg/ml]고우건강대조조[(29.56±15.53)pg/ml],차이유통계학의의(P<0.01);AML고백세포조혈청중IL-1β함량현저고우비고백세포조[(136.67±65.68)pg/ml비(69.85±48.35)pg/ml].IL-1β여외주혈백세포정직선상관관계(r=0.74,P<0.01).침윤조여비침윤조혈청중IL-1β수평위:(111.31±57.35)pg/ml비(79.68±43.42)pg/ml,차이유통계학의의.결론 AML환자혈청IL-1 β수평여기외주혈백세포수량유관,재일정정도상가반영질병적병정,가능삼여료백혈병세포조직침윤적궤제.
Objective The interleukin-1β (IL-13) expression in serum of acute myeloid leukemia (AML) patients was evaluated. To explore the significance of IL-1β in leukostasis and tissue infiltration by leukemic cells. Methods ELISA was used to investigate the contents of IL-1β in serum of 83 newly diagnosed with AML which contains 16 hyperleukocytic AML patients, and compared the IL-1β level between the hyperleukocytic AML group and non-hyperleukocytic AML group, the infiltrated group and non-infiltrated group. Results The content of IL-1β in AML serum [(88.23±36.30) pg/ml] was higher than that of in the control group[(29.56±15.53) pg/ml], with significant difference (P <0.01). There was a higher level for IL-1β in hyperleukocytic AML group[(136.67±65.68) pg/ml] than in non-hyperleukocytic AML group [(69.85±48.35) pg/ml],and there was a significant difference. IL-13 and peripheral blood cells were in linear correlation (r=0.74, P <0.01). There was a higher level for IL-1β in infiltrated group[(111.31 ±57.35) pg/ml] than in the other group [(79.68±43.42) pg/ml], and there was a significant difference. Conclusion The IL-1β may play an important role in leukostasis and tissue infiltration by leukemic cells in AML.